- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/57 - Protease inhibitors from animalsProtease inhibitors from humans
Patent holdings for IPC class A61K 38/57
Total number of patents in this class: 776
10-year publication summary
|
51
|
46
|
62
|
63
|
72
|
62
|
61
|
49
|
47
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| CSL Behring GmbH | 353 |
33 |
| Osiris Therapeutics, Inc. | 103 |
23 |
| Translate bio, Inc. | 414 |
19 |
| Kamada Ltd. | 59 |
15 |
| The Regents of the University of California | 20366 |
13 |
| The Regents of the University of Colorado, a body corporate | 2757 |
13 |
| Takeda Pharmaceutical Company Limited | 2712 |
12 |
| ProThera Biologics, Inc. | 22 |
11 |
| Cytonics Corporation | 24 |
10 |
| Oramed Ltd. | 27 |
10 |
| Children's Hospital Medical Center | 743 |
9 |
| Grifols Worldwide Operations Limited | 289 |
9 |
| Pharming Intellectual Property B.V. | 75 |
9 |
| James Cook University | 45 |
8 |
| The Trustees of the University of Pennsylvania | 4382 |
7 |
| Cedars-Sinai Medical Center | 1187 |
7 |
| CSL Limited | 252 |
7 |
| Combangio, Inc. | 28 |
7 |
| ViroPharma Biologics LLC | 56 |
7 |
| Daiichi Sankyo Company, Limited | 1876 |
6 |
| Other owners | 541 |